Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comvigen (Bivalent) Booster in Adults
NCT05930730Phase 2Unknown
- Sponsor
- Chulalongkorn University
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Modality
- Vaccine mRNA, mRNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChulaCov19 in coronavirus disease 2019 (COVID-19), sponsored by Chulalongkorn University. Status: unknown.
02
Drugs
ChulaCov19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05930730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05930730.